Axsome Therapeutics, Inc. (LON:0HKF)
182.61
-3.18 (-1.71%)
Feb 12, 2026, 4:58 PM GMT
Axsome Therapeutics Employees
Axsome Therapeutics had 816 employees as of September 30, 2025. The number of employees increased by 209 or 34.43% compared to the same quarter last year.
Employees
816
Change
209
Growth
34.43%
Revenue / Employee
511.70K GBP
Profits / Employee
-209.26K GBP
Market Cap
6.88B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 816 | 209 | 34.43% |
| Jun 30, 2025 | 846 | 257 | 43.63% |
| Mar 31, 2025 | 712 | 143 | 25.13% |
| Dec 31, 2024 | 683 | 138 | 25.32% |
| Sep 30, 2024 | 607 | 105 | 20.92% |
| Jun 30, 2024 | 589 | 167 | 39.57% |
| Mar 31, 2024 | 569 | 176 | 44.78% |
| Dec 31, 2023 | 545 | 162 | 42.30% |
| Sep 30, 2023 | 502 | 150 | 42.61% |
| Jun 30, 2023 | 422 | 224 | 113.13% |
| Mar 31, 2023 | 393 | 277 | 238.79% |
| Dec 31, 2022 | 383 | 275 | 254.63% |
| Sep 30, 2022 | 352 | 246 | 232.08% |
| Jun 30, 2022 | 198 | 105 | 112.90% |
| Mar 31, 2022 | 116 | 46 | 65.71% |
| Dec 31, 2021 | 108 | 48 | 80.00% |
| Sep 30, 2021 | 106 | 53 | 100.00% |
| Jun 30, 2021 | 93 | 50 | 116.28% |
| Mar 31, 2021 | 70 | 25 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Axsome Therapeutics News
- 15 days ago - AXSM: Leerink Partners Raises Price Target to $205, Maintains Outperform Rating | AXSM Stock News - GuruFocus
- 16 days ago - Noteworthy Tuesday Option Activity: TSLA, CVLT, AXSM - Nasdaq
- 16 days ago - Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 - GlobeNewsWire
- 19 days ago - Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline - Seeking Alpha
- 21 days ago - FRANKLIN STREET ADVISORS INC /NC Buys 10,000 Shares of Axsome Therapeutics Inc (AXSM) - GuruFocus
- 22 days ago - AXSM: RBC Capital Raises Price Target to $219 with Outperform Rating | AXSM Stock News - GuruFocus
- 23 days ago - HC Wainwright & Co. Raises Price Target for AXSM to $260 | AXSM Stock News - GuruFocus
- 27 days ago - Piper Sandler Raises Axsome Therapeutics (AXSM) Price Target to $223 | AXSM Stock News - GuruFocus